Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders
- 1 October 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 23 (5) , 484-495
- https://doi.org/10.1097/01.jcp.0000088915.02635.e8
Abstract
Based on the mood-stabilizing properties of carbamazepine and valproate, new anticonvulsants have been explored for use in bipolar disorders. One such agent, lamotrigine, has a novel clinical profile in that it may "stabilize mood from below," as it appears to maximally impact depressive symptoms in bipolar disorders. In this paper, we review the mechanisms of action of lamotrigine in an effort to understand the basis of its distinctive clinical use in the management of bipolar disorders as well as its diverse antiseizure effects. We consider lamotrigine mechanisms, emphasizing commonalities and dissociations among actions of lamotrigine, older mood stabilizers, and other anticonvulsants. Although ion channel effects, especially sodium channel blockade, may importantly contribute to antiseizure effects, such actions may be less central to lamotrigine thymoleptic effects. Antiglutamatergic and neuroprotective actions are important candidate mechanisms for lamotrigine psychotropic effects. Lamotrigine has a variable profile in kindling and contingent tolerance experiments and does not appear to have robust gamma-aminobutyric acid or monoaminergic actions. Lamotrigine intracellular signaling effects warrant investigation. Although lamotrigine mechanisms overlap those of other mood-stabilizing anticonvulsants, important dissociations suggest candidate mechanisms, which could contribute to lamotrigine's distinctive psychotropic profile.Keywords
This publication has 104 references indexed in Scilit:
- Stressful Life Events and Previous Episodes in the Etiology of Major Depression in Women: An Evaluation of the “Kindling” HypothesisAmerican Journal of Psychiatry, 2000
- Emergent Properties of Networks of Biological Signaling PathwaysScience, 1999
- A calcium antagonistic effect of the new antiepileptic drug lamotrigineEuropean Neuropsychopharmacology, 1997
- Attenuation of Cyclic AMP Production by CarbamazepineJournal of Neurochemistry, 1996
- Superiority of Lithium Over Verapamil in ManiaThe Journal of Clinical Psychiatry, 1996
- Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neuronsSynapse, 1996
- Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changesLife Sciences, 1995
- New antiepileptic drugsPharmacological Research, 1995
- The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's diseaseLife Sciences, 1994
- The effect of lamotrigine upon development of cortical kindled seizures in the ratNeuropharmacology, 1991